58 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective … procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective … procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
424B5
324zmpbc 9z
30 Dec 22
Prospectus supplement for primary offering
4:01pm
F-3
2jh lp0o31nod
29 Apr 22
Shelf registration (foreign)
8:14am
424B5
5k9cvuoepab93 hax8ay
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
a0kps5fqy mz
9 Feb 21
Prospectus supplement for primary offering
4:56pm
424B5
vf6g5aco yslawstg7hx
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-1.1
hzfytlok7h736b7c xkz
5 Mar 20
Report of Foreign Private Issuer
8:16am